Restricted accessResearch articleFirst published online 2026-4
The Patterns and Risk Factors for Antidepressant Drug Prescription in Thyroid Cancer Patients and Survivors: Analysis Based on the Korean National Health Insurance Service Database
Thyroid cancer is the most common endocrine malignancy and typically carries an excellent prognosis, especially in differentiated thyroid cancer (DTC). However, many survivors experience psychological challenges, including depression, which can significantly affect their long-term quality of life. While thyroid cancer treatment often involves surgery and hormone therapy, the relationship between treatment-related variables and new-onset depression remains poorly understood. Identifying clinical and treatment-related factors associated with depression is critical for improving postoperative survivorship care.
Methods:
We conducted a retrospective cohort study using data from the National Health Insurance Service–National Health Screening Cohort, which includes approximately 10% of the South Korean population aged 40–79 years. We included patients diagnosed with thyroid cancer (International Classification of Diseases version 10 [ICD-10] code C73) between 2002 and 2019 and excluded those with a prior diagnosis of depression or other cancers. Variables analyzed included treatment modality (active surveillance, lobectomy, total thyroidectomy [TT]), age, sex, income, smoking, alcohol consumption, physical activity, body mass index, blood pressure, presence of hypertension or diabetes, radioactive iodine (RAI) dose, and thyroid hormone replacement. The primary outcome was newly diagnosed depression, defined by a new prescription of antidepressants and corresponding diagnostic codes.
Results:
Among 6968 thyroid cancer patients included in the analysis, the risk of new-onset depression was significantly elevated in patients who underwent no treatment (hazard ratio [HR]: 1.33; 95% confidence interval [CI]: 1.06–1.66), lobectomy (HR: 1.30; 95% CI: 1.11–1.52), or TT (HR: 1.20; 95% CI: 1.09–1.32) compared with matched controls without thyroid cancer (all p < 0.05). There was no significant association between depression risk and cumulative RAI dose or levothyroxine dosage. Antidepressant prescription incidence was significantly higher within the first five years postdiagnosis but not beyond five years.
Conclusions:
Thyroid cancer diagnosis and treatment are associated with an increased risk of prescription of antidepressants in Korea.
PereiraM, WilliamsVL, Hallanger JohnsonJ, et al.Thyroid cancer incidence trends in the United States: Association with changes in professional guideline recommendations. Thyroid2020;30(8):1132–1140.
2.
Miranda-FilhoA, Lortet-TieulentJ, BrayF, et al.Thyroid cancer incidence trends by histology in 25 countries: A population-based study. Lancet Diabetes Endocrinol2021;9(4):225–234.
3.
HaugenBR, AlexanderEK, BibleKC, et al.2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid2016;26(1):1–133.
4.
DaviesL, WelchHG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg2014;140(4):317–322.
5.
DedhiaPH, SauckeMC, LongKL, et al.Physician perspectives of overdiagnosis and overtreatment of low-risk papillary thyroid cancer in the US. JAMA Netw Open2022;5(4):e228722; doi: 10.1001/jamanetworkopen.2022.8722
6.
JegerlehnerS, BulliardJL, AujeskyD, NICER Working Group. et al.Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. PLoS One2017;12(6):e0179387; doi: 10.1371/journal.pone.0179387
7.
NickelB, TanT, CvejicE, et al.Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment. JAMA Otolaryngol Head Neck Surg2019;145(3):231–238; doi: 10.1001/jamaoto.2018.3870
8.
SanftT, DenlingerCS, ArmenianS, et al.NCCN guidelines insights: Survivorship, version 2.2019: Featured updates to the NCCN guidelines. J Natl Compr Canc Netw2019;17(7):784–794.
9.
ConstantE, AdamS, SeronX, et al.Anxiety and depression, attention, and executive functions in hypothyroidism. J Int Neuropsychol Soc2005;11(5):535–544.
10.
DavisJ, TremontG. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol2007;32(1):49–65.
11.
CorreiaN, MullallyS, CookeG, et al.Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism. J Clin Endocrinol Metab2009;94(10):3789–3797.
12.
RyuJ, RyuYM, JungY-S, et al.Extent of thyroidectomy affects vocal and throat functions: A prospective observational study of lobectomy versus total thyroidectomy. Surgery2013;154(3):611–620.
13.
LandryV, SicilianiE, HenryM, et al.Health-related quality of life following total thyroidectomy and lobectomy for differentiated thyroid carcinoma: A systematic review. Curr Oncol2022;29(7):4386–4422.
14.
ChenW, LiJ, PengS, et al.Association of total thyroidectomy or thyroid lobectomy with the quality of life in patients with differentiated thyroid cancer with low to intermediate risk of recurrence. JAMA Surg2022;157(3):200–209.
15.
AhnD, SohnJH, JeonJH. Hypothyroidism following hemithyroidectomy: Incidence, risk factors, and clinical characteristics. J Clin Endocrinol Metab2016;101(4):1429–1436.
16.
WelchHG, DohertyGM. Saving thyroids—Overtreatment of small papillary cancers. N Engl J Med2018;379(4):310–312.
17.
EndoM. Quality of life is similar between total thyroidectomy and lobectomy in thyroid cancer survivors at 1 year after surgery. Clin Thyroidol2022;34(4):177–179.
18.
LanY, CaoL, SongQ, et al.The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross‐sectional study. Cancer Med2021;10(6):1989–2002.
19.
YanivD, VainerI, AmirI, et al.Quality of life following lobectomy versus total thyroidectomy is significantly related to hypothyroidism. J Surg Oncol2022;126(4):640–648.
20.
ChoiKW, KimY, FavaM, et al.Increased morbidity of major depressive disorder after thyroidectomy: A nationwide population-based study in South Korea. Thyroid2019;29(12):1713–1722.
21.
KimH, KimY, ShinM-H, et al.Risk of suicide attempt after thyroidectomy: A nationwide population study in South Korea. Psychiatry Investig2021;18(1):39–47.
22.
ApplewhiteMK, JamesBC, KaplanSP, et al.Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg2016;40(3):551–561.
23.
NotoB, AsmusI, SchäfersM, et al.Predictors of anxiety and depression in differentiated thyroid cancer survivors: Results of a cross-sectional study. Thyroid2022;32(9):1077–1085.
24.
ShinJ-Y, RougheadEE, ParkB-J, et al.Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): Nationwide self controlled case series study. BMJ2016;353:i2550.
25.
ChoJ, ChoiYJ, SuhM, et al.Air pollution as a risk factor for depressive episode in patients with cardiovascular disease, diabetes mellitus, or asthma. J Affect Disord2014;157:45–51.
26.
TagayS, HerpertzS, LangkafelM, et al.Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. Eur J Endocrinol2005;153(6):755–763; doi: 10.1530/eje.1.02047
27.
CaiM, GouJ. Symptoms and negative emotions in patients with advanced thyroid cancer: A prospective cross-sectional study. BMC Cancer2024;24(1):1418; doi: 10.1186/s12885-024-13169-7
28.
MassieMJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr2004;1(32):57–71; doi: 10.1093/jncimonographs/lgh014
29.
MejarehZN, AbdollahiB, HoseinipalangiZ, et al.Global, regional, and national prevalence of depression among cancer patients: A systematic review and meta-analysis. Indian J Psychiatry2021;63(6):527–535; doi: 10.4103/indianjpsychiatry.indianjpsychiatry_77_21
30.
ParkB, YounS, YiKK, et al.The prevalence of depression among patients with the top ten most common cancers in South Korea. Psychiatry Investig2017;14(5):618–625; doi: 10.4306/pi.2017.14.5.618
31.
UngvariZ, FeketeM, BudaA, et al.Depression increases cancer mortality by 23-83%: A meta-analysis of 65 studies across five major cancer types. Geroscience2025; doi: 10.1007/s11357-025-01676-9
32.
LeeJI, KimSH, TanAH, et al.Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health Qual Life Outcomes2010;8:101–110.
33.
KuśA, KjaergaardAD, MarouliE, et al.Thyroid function and mood disorders: A Mendelian randomization study. Thyroid2021;31(8):1171–1181.
34.
LuppaM, SikorskiC, LuckT, et al.Age-and gender-specific prevalence of depression in latest-life–systematic review and meta-analysis. J Affect Disord2012;136(3):212–221.
35.
KesslerRC, BerglundP, DemlerO, National Comorbidity Survey Replication. et al.The epidemiology of major depressive disorder: Results from the national comorbidity survey replication (NCS-R). JAMA2003;289(23):3095–3105.
36.
LangloisF, VuTTM, KergoatM-J, et al.The multiple dimensions of frailty: Physical capacity, cognition, and quality of life. Int Psychogeriatr2012;24(9):1429–1436.
37.
McPheeJS, FrenchDP, JacksonD, et al.Physical activity in older age: Perspectives for healthy ageing and frailty. Biogerontology2016;17(3):567–580.
38.
MhaolainAMN, FanCW, Romero-OrtunoR, et al.Frailty, depression, and anxiety in later life. Int Psychogeriatr2012;24(8):1265–1274.
39.
JiangC-h, ZhuF, QinT-T. Relationships between chronic diseases and depression among middle-aged and elderly people in China: A prospective study from CHARLS. Curr Med Sci2020;40(5):858–870.
40.
SrifuengfungM, AbrahamJ, AvidanMS, et al.Perioperative anxiety and depression in older adults: Epidemiology and treatment. Am J Geriatr Psychiatry2023;31(11):996–1008.
41.
BruceML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry2002;52(3):175–184.
42.
ShobabL, BurmanKD, WartofskyL. Sex differences in differentiated thyroid cancer. Thyroid2022;32(3):224–235.
43.
KweonS-S, ShinM-H, ChungI-J, et al.Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol2013;43(10):1039–1046.
44.
PattenSB, WangJL, WilliamsJV, et al.Descriptive epidemiology of major depression in Canada. Can J Psychiatry2006;51(2):84–90.
45.
XuS, HuangH, HuangY, et al.Comparison of lobectomy vs total thyroidectomy for intermediate-risk papillary thyroid carcinoma with lymph node metastasis. JAMA Surg2023;158(1):73–79.
46.
ColomboC, De LeoS, Di StefanoM, et al.Total thyroidectomy versus lobectomy for thyroid cancer: Single-center data and literature review. Ann Surg Oncol2021;28(8):4334–4344.
47.
HughesDT, Reyes-GastelumD, KovatchKJ, et al.Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes. Surgery2020;167(1):102–109.
48.
CordesJ, WoiteM, EngelkeC, et al.Hormone replacement therapy with L-thyroxine promotes working memory and concentration in thyroidectomized female patients after differentiated thyroid carcinoma. Int J Psychiatry Med2020;55(2):114–122.
49.
AltuntaşSÇ, HocaoğluÇ. Effects of chronic suppression or oversuppression of thyroid-stimulating hormone on psychological symptoms and sleep quality in patients with differentiated thyroid cancer. Horm Metab Res2021;53(10):683–691.
50.
NilssonJN, ElovssonR, ThorD, et al.Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism. Thyroid Res2022;15(1):8.
51.
LegrandA, BernierM-O, BressandA, et al.Health-related quality of life and radioiodine therapy in thyroid cancer patients: A before-and-after study. Qual Life Res2024;33(10):2721–2731.
52.
LiuY-B, ZuoL-J, LiuY-C, et al.Effect of psychological intervention on differentiated thyroid cancer patients in the treatment with radioactive iodine. Patient Prefer Adherence2023;17:731–738.
53.
BanihashemS, ArabzadehM, BahriRSJ, et al.Psychological status and quality of life associated with radioactive iodine treatment of patients with differentiated thyroid cancer: Results of hospital anxiety and depression scale and short-form (36) health survey. Indian J Nucl Med2020;35(3):216–221.
54.
AspariAR, LakshmanK. Effects of pre‐operative psychological status on post‐operative recovery: A prospective study. World J Surg2018;42(1):12–18.
55.
Dionisi-ViciM, FantoniM, BottoR, et al.Distress, anxiety, depression and unmet needs in thyroid cancer survivors: A longitudinal study. Endocrine2021;74(3):603–610.
56.
ForbesH, CarreiraH, FunstonG, et al.Early, medium and long-term mental health in cancer survivors compared with cancer-free comparators: Matched cohort study using linked UK electronic health records. EClinicalMedicine2024;76:102826; doi: 10.1016/j.eclinm.2024.102826
57.
OhCM, KongHJ, KimE, et al.National epidemiologic survey of thyroid cancer (NEST) in Korea. Epidemiol Health2018;40:e2018052; doi: 10.4178/epih.e2018052
